TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY
3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS
3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE
3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS
3.2 RESTRAINT
3.2.1 STRINGENT GOVERNMENTAL REGULATIONS
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS
3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS
3.4 CHALLENGE
3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 INDUSTRY INSIGHTS
7 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASEPTIC ISOLATORS
7.3 CONTAINMENT ISOLATORS
7.4 BIO ISOLATORS
7.5 SAMPLING AND WEIGHING ISOLATORS
7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
7.7 OTHERS
8 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE
8.1 OVERVIEW
8.2 CLASS III
8.3 ISO CLASS 5
9 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE
9.1 OVERVIEW
9.2 CLOSED SYSTEM
9.3 OPEN SYSTEM
10 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE
10.1 OVERVIEW
10.2 POSITIVE PRESSURE
10.3 NEGATIVE PRESSURE
11 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION
11.1 OVERVIEW
11.2 FLOOR STANDING
11.3 MOBILE
11.4 COMPACT
11.5 MODULAR
11.6 TABLE TOP
11.7 PORTABLE
12 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 STERILITY TESTING
12.3 PHARMACEUTICAL INDUSTRY
12.4 MICROBIOLOGY SAFETY CABINETS
12.5 SAMPLING/ WEIGHING/ DISTRIBUTION
12.6 ANIMAL LABORATORIES
12.7 MEDICAL DEVICE MANUFACTURING
12.8 OTHERS
13 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ACADEMIC AND RESEARCH INSTITUTES
13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
13.6 CONTRACT RESEARCH ORGANIZATION
14 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAILER
15 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 CHINA
15.1.3 INDIA
15.1.4 SOUTH KOREA
15.1.5 AUSTRALIA
15.1.6 SINGAPORE
15.1.7 MALAYSIA
15.1.8 THAILAND
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 COMPANY PROFILE
17.1 SKAN AG
17.1.1 COMPANY SNAPSHOT
17.1.2 SWOT ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 GEOGRAPHICAL PRESENCE
17.1.5 PRODUCT PORTFOLIO
17.1.6 RECENT DEVELOPMENTS
17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
17.2 COMECER S.P.A.
17.2.1 COMPANY SNAPSHOT
17.2.2 SWOT ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 GEOGRAPHICAL PRESENCE
17.2.5 PRODUCT PORTFOLIO
17.2.6 RECENT DEVELOPMENTS
17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
17.3 GETINGE AB.
17.3.1 COMPANY SNAPSHOT
17.3.2 SWOT ANALYSIS
17.3.3 REVENUE ANALYSIS
17.3.4 COMPANY SHARE ANALYSIS
17.3.5 GEOGRAPHICAL PRESENCE
17.3.6 PRODUCT PORTFOLIO
17.3.7 RECENT DEVELOPMENTS
17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
17.4 WABASH NATIONAL CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 SWOT ANALYSIS
17.4.3 REVENUE ANALYSIS
17.4.4 COMPANY SHARE ANALYSIS
17.4.5 GEOGRAPHICAL PRESENCE
17.4.6 PRODUCT PORTFOLIO
17.4.7 RECENT DEVELOPMENTS
17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
17.5 A. ROVANA LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS
?
17.6 AZBIL CORPORATION
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHICAL PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 BIOQUELL INC
17.7.1 COMPANY SNAPSHOT
17.7.2 GEOGRAPHICAL PRESENCE
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 CHIYODA CORPORATION
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHICAL PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 ENVAIR LIMITED
17.9.1 COMPANY SNAPSHOT
17.9.2 GEOGRAPHICAL PRESENCE
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.10 ESCO GROUP OF COMPANIES
17.10.1 COMPANY SNAPSHOT
17.10.2 GEOGRAPHICAL PRESENCE
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 FEDEGARI AUTOCLAVI S.P.A
17.11.1 COMPANY SNAPSHOT
17.11.2 GEOGRAPHICAL PRESENCE
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 GERMFREE
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 HECHT TECHNOLOGIE GMBH
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 HOSOKAWA
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHICAL PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 ITECO S.R.L.
17.15.1 COMPANY SNAPSHOT
17.15.2 GEOGRAPHICAL PRESENCE
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 GEOGRAPHICAL PRESENCE
17.16.4 PRODUCT PORTFOLIO
17.16.5 RECENT DEVELOPMENT
17.17 JACOMEX
17.17.1 COMPANY SNAPSHOT
17.17.2 GEOGRAPHICAL PRESENCE
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENTS
17.18 MBRAUN
17.18.1 COMPANY SNAPSHOT
17.18.2 GEOGRAPHICAL PRESENCE
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 NUAIRE
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH
17.20.1 COMPANY SNAPSHOT
17.20.2 GEOGRAPHICAL PRESENCE
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 ROBERT BOSCH GMBH
17.21.1 COMPANYSNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 GEOGRAPHICAL PRESENCE
17.21.4 PRODUCT PORTFOLIO
17.21.5 RECENT DEVELOPMENTS
17.22 STERILINE S.R.L.
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENTS
17.23 TAILIN
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENTS
17.24 TEMA SINERGIE S.P.A
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
17.25 VANRX PHARMASYSTEMS INC.
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENTS
18 CONCLUSION
19 QUESTIONNAIRE
20 RELATED REPORTS